Related Experiment Videos
Localization of a fibrin polymerization site
The Journal of Biological Chemistry
|April 10, 1981
Summary
A novel peptide from fibrinogen Fragment D1 inhibits fibrin clot formation by binding to fibrin monomer's NH2-terminal region. This peptide discovery offers insights into blood coagulation and potential therapeutic targets.
Area of Science:
- Biochemistry
- Molecular Biology
- Hematology
Background:
- Fibrin clot formation is crucial for hemostasis.
- Thrombin cleaves fibrinogen to initiate fibrin monomer polymerization.
- Polymerization involves interactions between fibrinogen's NH2-terminal and COOH-terminal (Fragment D) regions.
Purpose of the Study:
- To isolate and characterize a peptide that inhibits fibrin monomer polymerization.
- To identify the specific binding sites and interactions involved in fibrin polymerization.
- To elucidate the role of the gamma chain remnant of fibrinogen Fragment D1 in clot formation.
Main Methods:
- Isolation of a peptide from fibrinogen Fragment D1.
- Inhibition assays for fibrin monomer polymerization using thrombin and batroxobin.
- Binding studies using thrombin-treated disulfide knot and fibrin monomer.
- Determination of peptide sequences (NH2-terminal and COOH-terminal).
Main Results:
- A D1 peptide was isolated that binds to the NH2-terminal region of fibrinogen and inhibits polymerization.
- The peptide reduces polymerization rate and extent, increasing lag time.
- Binding occurs at approximately two sites per fibrin monomer, suggesting a site revealed by fibrinopeptide A removal.
- The gamma 373-410 region of fibrinogen contains a polymerization site complementary to the NH2-terminal site.
Conclusions:
- The D1 peptide acts as a polymerization inhibitor by blocking key interaction sites.
- Fibrinopeptide A removal exposes a polymerization site on the fibrin NH2-terminus.
- The gamma 373-410 region is critical for fibrin polymerization, offering a target for modulating clot formation.